2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
←
1
2
3
Date
Headline
Mar 24, 2020
CEL-SCI Increases Previously Announced Bought Deal to $7.7 Million
Mar 23, 2020
CEL-SCI Announces Bought Deal Offering
Mar 23, 2020
CEL-SCI to Develop LEAPS COVID-19 Immunotherapy in Collaboration with University of Georgia Center for Vaccines and Immunology
Mar 9, 2020
CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection
Feb 26, 2020
CEL-SCI Corporation Issues Letter to Shareholders
Feb 10, 2020
CEL-SCI Corporation Reports First Quarter Fiscal 2020 Financial Results
Feb 6, 2020
CEL-SCI to Present at 2020 BIO CEO & Investor Conference
Jan 10, 2020
CEL-SCI to Participate in Upcoming Investor Conferences
Jan 7, 2020
CEL-SCI Announces Full Exercise of Over-allotment Option by Aegis Capital Corp.